NYU LANGONE HEALTH

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1841-01-01

Employees: 10K

Market Cap: -

Website: http://www.nyulangone.org

Clinical Trials

The Sleep Amyloid, Slow WAve Race and Ethnicity Study

Recruiting

Conditions: Alzheimer Disease

Interventions: Procedure: PET-MR Scan
Drug: PiB

First Posted Date: 2019-01-24

Last Posted Date: 2024-06-24

Lead Sponsor: NYU Langone Health

Target Recruit Count: 210

Registration Number: NCT03814603

Locations: 🇺🇸
NYU Center for Brain Health, New York, New York, United States

Adherence to and Beliefs on Recommendations for Behavioral Treatment for Migraine

Not Applicable

Completed

Conditions: Migraine

Interventions: Behavioral: Treatment as Usual
Behavioral: Motivational Interviewing

First Posted Date: 2019-01-10

Last Posted Date: 2020-07-23

Lead Sponsor: NYU Langone Health

Target Recruit Count: 76

Registration Number: NCT03799211

Locations: 🇺🇸
NYU Langone, New York, New York, United States

Study of the Safety and Efficacy of a Caffeine-based Antifibrosis Cream in Patients With Breast Cancer Undergoing Radiation Therapy

Phase 2

Active, not recruiting

Conditions: Carcinoma Breast

Interventions: Drug: Caffeine anhydrous 5% added to Lipoderm Cream Base.
Other: Lipoderm Cream Base

First Posted Date: 2018-12-07

Last Posted Date: 2023-10-25

Lead Sponsor: NYU Langone Health

Target Recruit Count: 60

Registration Number: NCT03768492

Locations: 🇺🇸
New York University Medical Center, New York, New York, United States

Metabolic Sodium MRI to Assess Early Response of Breast Cancer to Neoadjuvant Chemotherapy

Not Applicable

Terminated

Conditions: Breast Cancer
Triple Negative Breast Cancer

Interventions: Diagnostic Test: Sodium (Na) Magnetic Resonance Imaging (MRI)
Diagnostic Test: Dynamic Contrast- Enhanced (DCE) MRI

First Posted Date: 2018-11-21

Last Posted Date: 2022-08-24

Lead Sponsor: NYU Langone Health

Target Recruit Count: 2

Registration Number: NCT03750240

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States

Trial of Nivolumab With Chemotherapy as Neoadjuvant Treatment in Inflammatory Breast Cancer (IBC)

Phase 2

Completed

Conditions: Breast Cancer

Interventions: Drug: Nivolumab 360mg
Drug: Paclitaxel 80mg/m^2
Drug: Cyclophosphamide 600mg/m^2
Drug: Doxorubicin 60mg/m^2
Drug: Paclitaxel 80mg/m^2 or Docetaxel 75mg/m^2
Drug: Trastuzumab 8mg/kg and 6 mg/kg
Drug: Pertuzumab 840mg and 420mg

First Posted Date: 2018-11-15

Last Posted Date: 2023-12-19

Lead Sponsor: NYU Langone Health

Target Recruit Count: 8

Registration Number: NCT03742986

Locations: 🇺🇸
Indiana University, Bloomington, Indiana, United States
🇺🇸
NYU Langone Health, New York, New York, United States

Trial of Community Health Worker-led Decision Coaching

Not Applicable

Completed

Conditions: Prostate Cancer

Interventions: Behavioral: Education Counseling Session for PSA Screening
Behavioral: General Health Counseling Coaching

First Posted Date: 2018-10-31

Last Posted Date: 2024-05-23

Lead Sponsor: NYU Langone Health

Target Recruit Count: 162

Registration Number: NCT03726320

Locations: 🇺🇸
New York University School of Medicine, New York, New York, United States

Linking Cognitive Functioning to Multimodal Imaging in Multiple Sclerosis (MS)

Terminated

Conditions: Cognition Disorders
Multiple Sclerosis

Interventions: Diagnostic Test: Siemens Biograph mMR (molecular MR)
Diagnostic Test: fMRI
Diagnostic Test: Diffusion Spectrum Imaging (DSI)

First Posted Date: 2018-10-29

Last Posted Date: 2021-03-26

Lead Sponsor: NYU Langone Health

Target Recruit Count: 6

Registration Number: NCT03723356

Locations: 🇺🇸
New York University School of Medicine, New York, New York, United States

Examine the Preliminary Effect of an Evidence-Based Practice (EBP) Consultation Model on Staff Fidelity to EBP

Not Applicable

Withdrawn

Conditions: Stress Disorders, Post-Traumatic

Interventions: Behavioral: TAU
Behavioral: TARGET

First Posted Date: 2018-10-29

Last Posted Date: 2019-07-23

Lead Sponsor: NYU Langone Health

Registration Number: NCT03722745

Enhanced Quality in Primary Care for Elders With Diabetes and Dementia

Not Applicable

Completed

Conditions: Alzheimer Disease
Dementia
Diabetes

Interventions: Behavioral: EQUIPED-ADRD Intervention
Behavioral: Control (CON)

First Posted Date: 2018-10-29

Last Posted Date: 2023-11-09

Lead Sponsor: NYU Langone Health

Target Recruit Count: 355

Registration Number: NCT03723707

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States

AZD1775 in Advanced Acute Myeloid Leukemia, Myelodysplastic Syndrome and Myelofibrosis

Phase 2

Terminated

Conditions: Myelofibroses
Acute Myeloid Leukemia
Myelodysplastic Syndromes

Interventions: Drug: Combination AZD1775 with AraC
Drug: AZD1775 only

First Posted Date: 2018-10-24

Last Posted Date: 2020-06-02

Lead Sponsor: NYU Langone Health

Target Recruit Count: 6

Registration Number: NCT03718143

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy